�鶹ӰԺ

Research will focus on improving the lives of people with Down syndrome

The BioFrontiers Institute at the University of Colorado launched its inaugural Sie Post-doctoral Fellowship Program in affiliation with the����on the Anschutz Medical Campus. The program will fund three post-doctoral researchers, Sie Fellows, who will focus on research that will improve the lives of individuals with Down syndrome.

The Sie Fellows research is co-funded by the BioFrontiers Institute and the��. Every two years, three Sie Fellows will be selected from a competitive grant process and will receive between $71,000 and $85,000 a year for two years.

Nobel laureate and Director of the BioFrontiers Institute��, BioFrontiers Chief Scientific Officer (CSO)��, and Executive Director of the Crnic Institute����were key in assessing the 44 applicants prior to deciding on the inaugural three recipients:����of CU-�鶹ӰԺ’s Department of Molecular, Cellular and Developmental Biology (MCDB),��Geertruida Josien Levenga��of CU-�鶹ӰԺ’s Institute of Behavioral Genetics, and����of MCDB.

“The projects being carried out by the Sie Fellows are key to significantly improving the lives of people with Down syndrome and to eradicating the medical and cognitive ill effects associated with the condition,” said Leinwand. “The support of early-stage post-doctoral fellows is crucial in any research operation, and these awards make it possible for faculty to increase their commitment to this important cause.”

BioFrontiers officially earned institute status in 2011 and brings together faculty members from the life sciences, physical sciences, computer science and engineering with the passion and skills needed to research across traditional disciplines and tackle difficult medical issues.

“The fact that there were 44 applicants for three awards underscores how exciting research for Down syndrome is, and the potential for real scientific contribution,” said Blumenthal. “With our Supergroup of 60 scientists working on Down syndrome and meeting monthly from different disciplines and different schools, we are truly making a difference for this special population and their families.”

“The Global Down Syndrome Foundation is pleased to add these outstanding researchers to our future portfolio of research we aim to fund and advocate for. Their research is already so relevant,” said Michelle Sie Whitten, executive director of the Global Down Syndrome Foundation, the fundraising and advocacy arm of the Crnic Institute.

Allen’s research involves genetic sequencing data from people with Down syndrome and their parents to understand how an extra copy of chromosome 21 puts people with Down syndrome at higher risk for health issues such as heart defects, thyroid conditions, leukemia, Alzheimer’s disease, and respiratory and hearing problems, but at lower risk for heart attack, stroke and solid-tumor cancers.

Levenga, who is a neuroscientist, is conducting research into ameliorating the seizures that afflict many people with Down syndrome.

Garrido-Lecca will test the hypothesis that alteration of microRNA levels in people with Down syndrome contributes to some of their health challenges.

Down syndrome is the most commonly occurring chromosomal condition, affecting one out of every 691 live births in the U.S., according to the Centers for Disease Control and Prevention. Because of the end of widespread institutionalization, better medical care, improved access to education and greater societal inclusion, people with Down syndrome are living longer and more productive lives, with the average life span increasing from 25 years in 1983 to 60 years today.

�鶹ӰԺ the BioFrontiers Institute

At the University of Colorado BioFrontiers Institute, researchers from the life sciences, physical sciences, computer science and engineering are working together to uncover new knowledge at the frontiers of science and partnering with industry to make their discoveries relevant.��

�鶹ӰԺ the Linda��Crnic��Institute for Down Syndrome

The����is the first medical and research institute with the mission to provide the best clinical care to people with Down syndrome, and to eradicate the medical and cognitive ill effects associated with the condition. Established in 2008, the Crnic Institute is a partnership between the��, the����and��. Headquartered on the Anschutz Medical Campus in Aurora, the Crnic Institute includes the����at Children’s Hospital Colorado. It partners both locally and globally to provide life-changing research and medical care for individuals with Down syndrome. The Crnic Institute is made possible by the generous support of the Anna and John J. Sie Foundation, and relies on the����for fundraising, education, awareness and government advocacy.�� It is a research and medical-based organization without political or religious affiliation or intention.

�鶹ӰԺ the Global Down Syndrome Foundation

The����is a public nonprofit 501(c)(3) dedicated to significantly improving the lives of people with Down syndrome through research, medical care, education and advocacy. Established in 2009, Global has the primary focus of supporting the Linda��Crnic��Institute for Down Syndrome, the first academic home in the U.S. committed to research and medical care for people with the condition. Fundraising and government advocacy that corrects the alarming disparity of national funding for people with Down syndrome is a major short-term goal. Global organizes the Be Beautiful Be Yourself Fashion Show – the single-largest annual fundraiser benefiting people with Down syndrome.�� Global also organizes and funds many programs and conferences, including the Dare to Play Football and Cheer Camps, Global Down Syndrome Educational Series, and the Be Beautiful Be Yourself Dance Class. Global is an inclusive organization without political or religious affiliation or intention.